Results 121 to 130 of about 30,219 (216)

Obesity and cancer: Relevance of DNA damage response. [PDF]

Transl Oncol
Deshmukh B, Ajay AK, Bhat MK.
europepmc   +1 more source

The DDR-immune fitness score: a biomarker for guiding parp and immunotherapy synergy in extensive-stage small cell lung cancer. [PDF]

Front Oncol
Zhang Y, Chen X, Wang D, Zhou X, Wang Y, Zhang G, Liu X.   +6 more
europepmc   +1 more source

Characteristics of Germline and Somatic Mutations of DNA Repair Genes in Korean Men with Prostate Cancer. [PDF]

World J Mens Health
Lee H, Ho JN, Song SH, Oh JJ, Huh JS, Kim HM, Kim KH, Kim S, Byun SS.   +8 more
europepmc   +1 more source

Editorial: Overcoming resistance in DDR inhibition: new targets and therapeutic strategies. [PDF]

Front Mol Biosci
Tsai CL, Gonçalves AC, Ahmed Z.
europepmc   +1 more source

Exploiting synthetic lethality in epithelial ovarian cancer: multi-dimensional approaches beyond DNA damage repair. [PDF]

Mol Cancer
Bigdeli M, Tremblay E, Provencher D, Mes-Masson AM, Rodier F.   +4 more
europepmc   +1 more source

Manipulating DNA repair and the DNA damage response to improve cancer therapy. [PDF]

NAR Cancer
Lan L, Fouquerel E.
europepmc   +1 more source

DNA damage induced by HIV-1 Vpr triggers epigenetic remodeling and transcriptional programs to enhance virus transcription and latency reactivation. [PDF]

PLoS Biol
Saladino N, Leavitt E, Wong HT, Ji JH, Ebrahimi D, Salamango DJ.   +5 more
europepmc   +1 more source

Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer-A Comprehensive Review of Literature. [PDF]

Int J Mol Sci
Kciuk M, Wanke K, Marciniak B, Kołat D, Aleksandrowicz M, Mujwar S, Ainane T, Kontek R.   +7 more
europepmc   +1 more source

Prevalence and Clinical Associations of Germline DDR Variants in Prostate Cancer: Real-World Evidence from a 122-Patient Turkish Cohort. [PDF]

Genes (Basel)
Akay S, Ozdemir TR, Ozer Kaya O, Degirmenci M, Unal OU.   +4 more
europepmc   +1 more source